The 20 most sought-after pediatric Chinese patent medicines in pharmacies: 14 brands with over 100 million yuan and 2 products with an increase of over 30%

Medicines Network June 3 last year, the new version of the Drug Administration Law officially launched, explicitly encourage the development and innovation of children's medicines, support the development of children's biological characteristics in line with the biological characteristics of children's new varieties, dosage forms and specifications, children's drugs to give priority review and approvalWhile research and development are good, the retail pharmacy market is growing steadilyMi-net data show that in 2019, China's urban retail pharmacy terminal pediatric chinese medicine sales exceeded 5 billion scale, product TOP20, 8 is exclusive, Jin Zhen oral solution and children's anti-cough oral fluid growth of more than 30%; In, 14 brands have sold hundreds of millions, of which, Yabao Pharmaceutical Group's Ding Guier umbilical cord paste and China Resources 39 (Yuzhuang) pharmaceutical children's cold particles are more than 400 million;20
pediatric chinese medicine drugstores sell "fire"! 8
exclusive products, 14
brands have sold 100 millionIn recent years, China's urban retail pharmacy terminal pediatric chinese medicine sales (units: million yuan)meters of the net data show that in recent years, China's urban publichospitals, county-level public hospitals, urban community centers and township health hospitals (China's public medical institutions) terminal pediatric chinese medicine market sales growth slowed, but in 2019 exceeded 5 billion scaleAmong them, the product TOP20 sales accounted for more than 75%, the market concentration is highIn 2019, China's urban retailpharmaciesterminal pediatric Chinese medicine products TOP20 (unit: million yuan)products TOP20, 8 are exclusive products, 15 sales of more than 100 million yuanIn subcategory, pediatric cough and sputum drugs were the most, up to 9, followed by pediatric cold drugs, with 4 　　In 2019, 14 of China's urban retail pharmacies in the end pediatrics into drugs brand TOP20 (units: 10,000 yuan) brand TOP20, there are 14 sales of more than 100 million yuan Among them, Yabao Pharmaceutical Group's Ding Guier umbilical paste and China Resources 39 (Yuzhuang) pharmaceutical children's cold particles are more than 400 million; Jichuan Pharmaceutical Group's children's sage hot particles into the 300 million echelon for the first time; 　　4.19 billion ! Ding Guier umbilical paste leading In recent years, China's urban retail pharmacy terminal DingGuier umbilical paste sales (unit: million yuan) Ding Guier umbilical paste is the exclusive product of Yabao Pharmaceuticals, in recent years in China's urban retail pharmacy terminal sales are more than 400 million yuan, 2019 sales of 419 million yuan, an increase of 0.63% year-on-year 　　Abao Pharmaceuticals in the annual report mentioned that Ding Guier umbilical paste is the company's children's drugs fist products, since the listing in 1992, after more than 20 years of sustained development, occupied an important seat in the market, its sales coverage of the country's key provinces and cities and prefecture-level cities, long-term in the retail terminal digestive tract drug lead In the field of pediatrics, Abao Pharmaceuticals has formed a digestive tract medication based on Ding Guier umbilical cord paste, pediatric diarrhea paste, pediatric diarrhea paste, granary spleen gel and lactic acid micromycoin tablets, to children's puritanous hydrostatic oral solution, pediatric cough asthma oral solution, pediatric lung fever and wheezing particles, pediatric acetaminophen-based respiratory drug, to glucose zinc oral acid and calcium calcium-based supplementary medicine 　　Children's cold particles fierce competition, China Resources 39 market accounted for more than 85% of the in recent years, China's urban retail pharmacy terminal son cold dispersal / granule sales (unit: million yuan) 2019 pediatric cold particles in China's urban retail pharmacy terminal sales reached 485 million yuan, down 3.68% YoY It is worth mentioning that the fierce competition of children's cold particles, the number of manufacturers more than 80, of which, China Resources 39 (Yuzhuang) pharmaceutical market share in the first place, accounting for more than 85% China Resources 39 in the annual report said that in the future will carry out children's cold particles and other core varieties of product strength to improve, and continue to build and cultivate large varieties 　　Jinzhen oral liquid from 30 million
to 154 in recent years, China's urban retail pharmacy terminal JinZhen oral liquid sales (units: million yuan) JinZhen oral liquid is the exclusive product of Kangyuan Pharmaceuticals, sales growth in recent years, from 33.04 million yuan in 2015 to 154 million yuan in 2019, growth rate of more than 30% Kangyuan Pharmaceuticals mentioned in the listed varieties research and development plan, will continue to carry out medical insurance or key varieties of basic drugs after the market in-depth study, orderly promotion of Jinzhen oral liquid, hot-to-drug injection and other major varieties of evidence-based medical clinical research, for the listed varieties of academic promotion and clinical rational drug use to provide strong support 　　Over 30% ! The rapid growth of oral liquid sales of children's anti-cough
in recent years, China's urban retail pharmacy terminal small children anti-cough oral liquid sales (units: million yuan) children's anti-cough oral liquid is the exclusive product of Lunan Hopu Pharmaceuticals, sales growth in recent years, 2018 exceeded the scale of 100 million yuan, 2019 growth of 34.47 percent, up to 148 million yuan In March this year, Lunan Pharmaceuticals' official website released new evidence of evidence-based medicine for the oral fluid of pediatric anti-cough Data show that the pediatric anti-cough oral solution is a kind of traditional Chinese medicine with the effect of heat-clearing lung, anti-cough, can be used to treat the cough caused by the sputum fever lung in children, often used in clinical combination with azithromycin for the treatment of pediatric mycoplasma pneumonia, and achieved good results 　　Data description: Mi net China's urban retail pharmacy terminal competition pattern, referred to as "city" of the statistical scope is: 293 cities and above, that is, all cities in China at the level and above of the physical pharmacy (excluding county and rural physical pharmacies); Source: Internet Database, Public Company Announcement
Note: If there are omissions, welcome to point the finger right!